FDA reaffirms its oversight of press materials
Matthew Arnold
November 30 2012
The FDA issued a rare untitled letter concerning a pitch letter—a reminder that the agency does not consider press materials ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.